DDMoRe - Drug Disease Model Resources

Edit this information sheet | All information sheets
General information
URL http://ddmore.eu/
Description To facilitate knowledge integration for decision making. a public drug and disease model repository supported by an open source interoperability framework which will provide access to existing modelling tools and those of the future.a collection of computational models of disease and drug action that have been used in pharmaceutical and/or academic research.
Organisation The DDMoRe consortium is a 5-year IMI project (www.imi.europa.eu), involving 27 partners (drawn from the Pharmaceutical Industry, Academia and Small to Medium Enterprises).
Type of service Storage facility
Legislation Netherlands
Usage and appreciation 2,811 downloads from 2015-01-01 to 2015-02-01 3,942 downloads from 2015-02-01 to 2015-02-18Download via SourceForge http://sourceforge.net/projects/ddmore/
Support organisation The project is supported by the European Union’s Seventh Framework Program (FP7) and European Federation of Pharmaceutical Industries and Associations’ companies (DDMoRe; EFPIA; FP7/2007-2013; contract #115156), under the Innovative Medical Initiative (IMI), a large-scale public-private partnership between the European Union and the pharmaceutical industry association EFPIA.
Context
Stage in the research project During
Postion within the research process4. Preserving data, 5. Giving access to data, 6. Re-using data
Domain 3. Shared Research Domain, 5. Public Domain
Type of data 3. Processed data and data representations
Data curation-- Unknown --The centrepoint of the DDMoRe strategy will be the development and promotion of a robust set of standards: one for model and workflow encoding, and another for storage and transfer of models, and related data based on a communal ontology-based metadata standard
Data classification Klasse 3 voor openbare informatie, Klasse 2 voor interne informatie [voor een beperkte groep]The model repository will be made available as a public instance, but will be portable and developed under existing GPL-compatible licenses, allowing integration of private or customized versions within organizations.
Administrative information
Funding € 21,165,061 eenmaligThe European Commission's Seventh Framework Programme contributes €1 billion to the IMI research programme. That amount is matched by in kind contributions worth at least another €1 billion from the pharmaceutical companies that are members of EFPIA, the European Federation of Pharmaceutical Industries and Associations.
Depositor agreement No information was found
User agreement No information was found
Policy To facilitate knowledge integration for decision making DDMoRe is developing a public drug and disease model repository supported by an open source interoperability framework which will provide access to existing modelling tools and those of the future. DDMoRe is also developing the Modelling Description Language (MDL), a single, unified language which will capture the definition of models together with their parameter and data attributes irrespective of the target software for performing the modelling and simulation task.
Intellectual property No information was found
Data curation strategy No information was found
Target group
Faculty Science
Primary target group industry, regulatory agencies, health care providers and academic teaching and research programmes
Secondary target group
Classification of the service
Availability Open
Integrity ?
Confidentiality ?
Formats
Accepted metadata formats DDMoRe is developing the Modelling Description Language (MDL), a single, unified language which will capture the definition of models together with their parameter and data attributes irrespective of the target software for performing the modelling and simulation task.
Accepted content types models
Accepted preferred formats ?
Accepteerde file formats PharmML model code (extension xml), MDL model code (extension , NMTRAN model code (extension mod), Data (extension csv or txt), Implementation information (extension txt)PharmML representation is required
Storage
Maximum size of deposits ?
Version management Yes
Quality control ?
Access
Access requirements ?
Tools / Interfaces for access No information was found
(Persistent) identifiers
Preservation
Long term guarantees ?
Complies with international standards for trusted repositories Not certified
Preservation strategy ?
Costs
Storage No information was found
Access No information was found
Preservation
Special conditions
Agreements with Leiden University None
Risks